Current Molecular Medicine
ISSN 1566-5240 · Bentham Science Publishers · United Arab Emirates · active 2001–2026
Flagged for closer checking
Publisher listed on Beall's archive (frozen 2017). Cross-check with DOAJ and Think.Check.Submit before submission.
This is a screening signal, not a verdict. How this check works.
Metrics
- Best Scimago quartile (2025)
- Q2
- Cites per paper (2y)
- 1.7
- SJR
- 0.649
- h-index
- 133
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 1 November 2026 (venue index build).
Scimago Journal Rank 2025
In the Scimago Journal Rank 2025 edition, Current Molecular Medicine is Q2 in 1 of its 4 subject categories and Q3 in the other 3. Its best category quartile is Q2.
| Subject category | Quartile | Rank in category |
|---|---|---|
| Medicine (miscellaneous) | Q2 | #1,022 of 2,517 |
| Molecular Medicine | Q3 | #110 of 181 |
| Biochemistry | Q3 | #233 of 449 |
| Molecular Biology | Q3 | #257 of 425 |
- Cites per document (2 years, Scopus)
- 3.30
- Documents indexed in 2025 (Scopus)
- 196
OpenAlex counts about 1.7 citations per paper over two years; Scopus, through Scimago, counts 3.30 per document. The two databases index different journals, documents and citations, so the figures differ. Neither is a Clarivate Journal Impact Factor.
The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Indexing & access
- Indexed in
- ScopusWeb of SciencePubMed
- Access status:
- hybrid. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Current Molecular Medicine a predatory journal?
Our screening flags Current Molecular Medicine as a possible predatory venue because its publisher appears on Beall's archive, which has been frozen since 2017. Treat this as a prompt to check carefully, not a verdict: verify against DOAJ and Think. Check. Submit before submitting.
Is Current Molecular Medicine indexed in Scopus or Web of Science?
Per our venue index, Current Molecular Medicine appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Current Molecular Medicine?
Papers in Current Molecular Medicine are cited about 1.7 times each within two years of publication, and Scimago places it in Q2, with an h-index of 133. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Current Molecular Medicine (Q1, Q2, Q3, or Q4)?
In the Scimago Journal Rank 2025 edition, Current Molecular Medicine is Q2 in 1 of its 4 subject categories and Q3 in the other 3. By category: Medicine (miscellaneous): Q2, #1,022 of 2,517; Molecular Medicine: Q3, #110 of 181; Biochemistry: Q3, #233 of 449; Molecular Biology: Q3, #257 of 425. Its best category quartile is Q2. Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Current Molecular Medicine is cited about 1.7 times per paper over two years, with an h-index of 133.
What is the Web of Science (JCR) quartile of Current Molecular Medicine?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Current Molecular Medicine. The open equivalent is its best Scimago quartile, Q2 in Medicine (miscellaneous), derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Current Molecular Medicine open access?
Our index records its access status as "hybrid". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Ready to submit? Tools for your next paper
Similar venues
Compare it with its peers: Ranked Molecular Biology journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.